Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of CDK4/6 Inhibition in Breast Cancer.
Murphy CG, Dickler MN. Murphy CG, et al. Among authors: dickler mn. Oncologist. 2015 May;20(5):483-90. doi: 10.1634/theoncologist.2014-0443. Epub 2015 Apr 15. Oncologist. 2015. PMID: 25876993 Free PMC article. Review.
Bevacizumab for advanced breast cancer.
Traina TA, Rugo HS, Dickler M. Traina TA, et al. Hematol Oncol Clin North Am. 2007 Apr;21(2):303-19. doi: 10.1016/j.hoc.2007.03.006. Hematol Oncol Clin North Am. 2007. PMID: 17512451 Review.
A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.
Dickler MN, Rugo HS, Eberle CA, Brogi E, Caravelli JF, Panageas KS, Boyd J, Yeh B, Lake DE, Dang CT, Gilewski TA, Bromberg JF, Seidman AD, D'Andrea GM, Moasser MM, Melisko M, Park JW, Dancey J, Norton L, Hudis CA. Dickler MN, et al. Clin Cancer Res. 2008 Dec 1;14(23):7878-83. doi: 10.1158/1078-0432.CCR-08-0141. Clin Cancer Res. 2008. PMID: 19047117 Free PMC article. Clinical Trial.
Aromatase inhibitors and arthralgia: a growing pain?
Murphy C, Hudis CA, Dickler MN. Murphy C, et al. Among authors: dickler mn. Oncology (Williston Park). 2008 Nov 15;22(12):1424, 1426. Oncology (Williston Park). 2008. PMID: 19322950 Free article. No abstract available.
Bevacizumab for advanced breast cancer.
Goldfarb SB, Traina TA, Dickler MN. Goldfarb SB, et al. Among authors: dickler mn. Womens Health (Lond). 2010 Jan;6(1):17-25. doi: 10.2217/whe.09.71. Womens Health (Lond). 2010. PMID: 20001867 Free article. Review.
HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab.
Modi S, Stopeck A, Linden H, Solit D, Chandarlapaty S, Rosen N, D'Andrea G, Dickler M, Moynahan ME, Sugarman S, Ma W, Patil S, Norton L, Hannah AL, Hudis C. Modi S, et al. Clin Cancer Res. 2011 Aug 1;17(15):5132-9. doi: 10.1158/1078-0432.CCR-11-0072. Epub 2011 May 10. Clin Cancer Res. 2011. PMID: 21558407 Clinical Trial.
Characteristics of oral mucosal events related to bevacizumab treatment.
Gavrilovic IT, Balagula Y, Rosen AC, Ramaswamy V, Dickler MN, Dunkel IJ, Lacouture ME. Gavrilovic IT, et al. Among authors: dickler mn. Oncologist. 2012;17(2):274-8. doi: 10.1634/theoncologist.2011-0198. Epub 2012 Jan 26. Oncologist. 2012. PMID: 22282905 Free PMC article.
Alopecia with endocrine therapies in patients with cancer.
Saggar V, Wu S, Dickler MN, Lacouture ME. Saggar V, et al. Among authors: dickler mn. Oncologist. 2013;18(10):1126-34. doi: 10.1634/theoncologist.2013-0193. Epub 2013 Sep 13. Oncologist. 2013. PMID: 24037977 Free PMC article.
Endocrine therapy for advanced breast cancer.
Shah PD, Dickler MN. Shah PD, et al. Among authors: dickler mn. Clin Adv Hematol Oncol. 2014 Apr;12(4):214-23. Clin Adv Hematol Oncol. 2014. PMID: 25003351 Review.
120 results